Valuation: Deva Holding

Market Cap 15.03B 298M 271M 250M 226M 426M 28.01B 443M 3.01B 1.19B 1.12B 1.1B 47.53B P/E 2024
226x
P/E 2025 -15.5x
Enterprise Value 17.42B 346M 314M 290M 262M 494M 32.46B 513M 3.49B 1.38B 1.3B 1.27B 55.08B EV / Sales 2024
1.27x
EV / Sales 2025 0.78x
Free-Float
17.78%
Yield 2024 *
-
Yield 2025 -
1 day-2.59%
1 week-6.65%
Current month+8.52%
1 month-3.78%
3 months+3.58%
6 months+12.58%
Current year+19.86%
1 week 74.85
Extreme 74.85
80.8
1 month 66.65
Extreme 66.65
87.2
Current year 57.5
Extreme 57.5
109.3
1 year 57.5
Extreme 57.5
109.3
3 years 51
Extreme 51
109.3
5 years 24.3
Extreme 24.3
109.3
10 years 3.08
Extreme 3.08
109.3
Manager TitleAgeSince
Chief Executive Officer - 2006-07-13
Director of Finance/CFO - 2025-10-31
Director of Finance/CFO 47 2008-03-13
Director TitleAgeSince
Chairman - 2006-07-13
Director/Board Member - 2013-05-21
Director/Board Member - 2015-04-07
Change 5-day change 1-year change 3-year change Capi.($)
-2.59%-6.65%+20.63%-12.77% 306M
-0.82%+5.74%+39.64%+143.26% 1,286B
-1.12%+2.29%+44.21%+89.89% 688B
-0.16%+1.11%+26.76%+114.06% 521B
+1.14%+4.87%+43.06%+71.97% 386B
-2.23%-1.55%+55.47%+42.54% 364B
+1.27%+2.01%+30.01%+62.35% 302B
+0.37%+0.75%+3.71%+39.09% 287B
-0.72%+0.41%+37.29%+69.33% 252B
-0.30%+0.41%+34.04%+123.32% 208B
Average -0.39%+1.45%+33.48%+74.30% 429B
Weighted average by Cap. -0.40%+3.26%+36.97%+98.26%

Financials

2024 2025
Net sales 15.46B 307M 279M 258M 233M 438M 28.8B 455M 3.09B 1.23B 1.15B 1.13B 48.88B 19.25B 382M 347M 321M 290M 546M 35.86B 567M 3.85B 1.53B 1.43B 1.4B 60.85B
Net income 69.42M 1.38M 1.25M 1.16M 1.04M 1.97M 129M 2.04M 13.9M 5.51M 5.17M 5.06M 219M -807M -16.01M -14.56M -13.45M -12.14M -22.88M -1.5B -23.76M -162M -64.03M -60.06M -58.81M -2.55B
Net Debt 4B 79.29M 72.07M 66.59M 60.12M 113M 7.45B 118M 800M 317M 297M 291M 12.63B 2.39B 47.42M 43.11M 39.83M 35.96M 67.77M 4.45B 70.37M 478M 190M 178M 174M 7.56B
Projected Income Statement - Annual - Deva Holding
Logo Deva Holding
Deva Holding AS is a Turkey-based pharmaceutical company that is primarily engaged in the production and marketing of finished pharmaceutical products, pharmaceutical ingredients and veterinary products, as well as animal health products, among others. The Company has four production facilities in Turkey. Its production facilities include the Tokapi, Cerezkoy I, Cerezkoy II and Kartepe production plants. The Company’s product portfolio comprises 73 drugs, which are available on the market in 177 various forms. It offers products, such as Azitro, Alemax, Cefax, Inhibace, Imatis, Hydrea, Kardozin, Kristapen, Magcar, Magnesie Calcinee, Nostil, Oceral, Remidon, Prolixin and Quet, among others. The Company has two subsidiaries, namely Vetaa Veteriner ve Tarim Ilaclari A.S. and Deva Holding NZ Ltd.
Employees
3,079
Date Price Change Volume
26-11-16 TRY 75.15 -2.59% 318,712
26-11-13 TRY 77.15 -1.47% 268,004
26-11-12 TRY 78.30 +3.30% 356,363
26-11-11 TRY 75.80 -2.57% 366,508
26-11-10 TRY 77.80 -2.02% 352,265
  1. Stock Market
  2. Stocks
  3. DEVA Stock